Expression regulation of co-inhibitory molecules on human natural killer cells in response to cytokine stimulations

被引:65
作者
Sun, Haoyu [1 ]
Sun, Cheng [1 ]
Xiao, Weihua [1 ,2 ]
机构
[1] Univ Sci & Technol China, Sch Life Sci, Inst Immunol, Hefei 230027, Anhui, Peoples R China
[2] Hefei Natl Lab Phys Sci Microscale, Hefei 230027, Anhui, Peoples R China
基金
中国国家自然科学基金;
关键词
Co-inhibitory molecule; Cytokine; Gene regulation; Natural killer cell; DILATED CARDIOMYOPATHY; HUMAN INTERLEUKIN-12; CUTTING EDGE; T-CELLS; LAG-3; ACTIVATION; PD-1; PATHWAY; PROTEIN; MOTIF;
D O I
10.1016/j.cyto.2013.09.016
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Co-inhibitory molecules have become the key targets in cancer immunotherapy with the strategy of blocking immune checkpoints to reverse the pathogenic regulation of T cells. However, their expression regulations in NK cells, the most important innate immune cells against tumor, remain largely undefined. In this study, we showed that the expressions of co-inhibitors on NK cells, including LAG-3, PD-1, and TIGIT, are differently regulated by cytokines IL-10, IL-12, IL-15, IFN-alpha and TGF-beta. Among the tested cytokines, IL-12 is the most powerful inducer of LAG-3, and TGF-beta is the strongest suppresser of PD-1. Notably, the expression of these co-inhibitors responds to the time course of stimulus progressively. Together, these findings illustrated that the co-inhibitors on NK cells express differently in response to cytokine stimulations of IL-10, IL-12, IL-15, IFN-alpha, and TGF-beta, providing an initial information on the expression regulation of co-inhibitors in human NK cells. (C) 2013 Elsevier Ltd. All rights reserved.
引用
收藏
页码:33 / 41
页数:9
相关论文
共 56 条
  • [1] Opposite role for interleukin-4 and interferon-gamma on CD30 and lymphocyte activation gene-3 (LAG-3) expression by activated naive T cells
    Annunziato, F
    Manetti, R
    Cosmi, L
    Galli, G
    Heusser, CH
    Romagnani, S
    Maggi, E
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 1997, 27 (09) : 2239 - 2244
  • [2] Expression and release of LAG-3-encoded protein by human CD4(+) T cells are associated with IFN-gamma production
    Annunziato, F
    Manetti, R
    Tomasevic, L
    Giudizi, MG
    Biagiotti, R
    Gianno, V
    Germano, P
    Mavilia, C
    Maggi, E
    Romagnani, S
    [J]. FASEB JOURNAL, 1996, 10 (07) : 769 - 776
  • [3] From IL-2 to IL-37: the expanding spectrum of anti-inflammatory cytokines
    Banchereau, Jacques
    Pascual, Virginia
    O'Garra, Anne
    [J]. NATURE IMMUNOLOGY, 2012, 13 (10) : 925 - 931
  • [4] Endothelial Cells Augment the Suppressive Function of CD4+ CD25+Foxp3+ Regulatory T Cells: Involvement of Programmed Death-1 and IL-10
    Bedke, Tanja
    Pretsch, Leah
    Karakhanova, Svetlana
    Enk, Alexander H.
    Mahnke, Karsten
    [J]. JOURNAL OF IMMUNOLOGY, 2010, 184 (10) : 5562 - 5570
  • [5] The PD-1/PD-L1 axis modulates the natural killer cell versus multiple myeloma effect: a therapeutic target for CT-011, a novel monoclonal anti-PD-1 antibody
    Benson, Don M., Jr.
    Bakan, Courtney E.
    Mishra, Anjali
    Hofmeister, Craig C.
    Efebera, Yvonne
    Becknell, Brian
    Baiocchi, Robert A.
    Zhang, Jianying
    Yu, Jianhua
    Smith, Megan K.
    Greenfield, Carli N.
    Porcu, Pierluigi
    Devine, Steven M.
    Rotem-Yehudar, Rinat
    Lozanski, Gerard
    Byrd, John C.
    Caligiuri, Michael A.
    [J]. BLOOD, 2010, 116 (13) : 2286 - 2294
  • [6] Cutting Edge: Accelerated Autoimmune Diabetes in the Absence of LAG-3
    Bettini, Maria
    Szymczak-Workman, Andrea L.
    Forbes, Karen
    Castellaw, Ashley H.
    Selby, Mark
    Pan, Xiaoyu
    Drake, Charles G.
    Korman, Alan J.
    Vignali, Dario A. A.
    [J]. JOURNAL OF IMMUNOLOGY, 2011, 187 (07) : 3493 - 3498
  • [7] Phase I Study of Single-Agent Anti-Programmed Death-1 (MDX-1106) in Refractory Solid Tumors: Safety, Clinical Activity, Pharmacodynamics, and Immunologic Correlates
    Brahmer, Julie R.
    Drake, Charles G.
    Wollner, Ira
    Powderly, John D.
    Picus, Joel
    Sharfman, William H.
    Stankevich, Elizabeth
    Pons, Alice
    Salay, Theresa M.
    McMiller, Tracee L.
    Gilson, Marta M.
    Wang, Changyu
    Selby, Mark
    Taube, Janis M.
    Anders, Robert
    Chen, Lieping
    Korman, Alan J.
    Pardoll, Drew M.
    Lowy, Israel
    Topalian, Suzanne L.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (19) : 3167 - 3175
  • [8] Regulation of expression of the human lymphocyte activation gene-3 (LAG-3) molecule, a ligand for MHC class II
    Bruniquel, D
    Borie, N
    Hannier, S
    Triebel, F
    [J]. IMMUNOGENETICS, 1998, 48 (02) : 116 - 124
  • [9] CD4 T cells in hepatic immune tolerance
    Carambia, Antonella
    Herkel, Johannes
    [J]. JOURNAL OF AUTOIMMUNITY, 2010, 34 (01) : 23 - 28
  • [10] A new reliable bioassay for determining the biological activity of human interleukin-12 by using human NK cell line NKG cells
    Cheng, Min
    Fei, Baozhen
    Zheng, Xiaodong
    Chen, Yongyan
    Sun, Rui
    Wei, Haiming
    Tian, Zhigang
    [J]. INTERNATIONAL IMMUNOPHARMACOLOGY, 2012, 13 (01) : 109 - 113